• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts Dermatology

Category Archive

  • Dermatology / May 29, 2021

    Mycosis fungoides-derived exosomes promote cell motility, are enriched with miR-155 and miR-1246, and their plasma cell-free expression may serve as potential biomarkers for disease burden.

    View Post
  • Dermatology / December 10, 2020

    Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after anti-TNF failure.

    View Post
  • Dermatology / January 16, 2021

    Kawasaki disease for the pediatric dermatologist: Skin manifestations and new insights into the pathophysiology.

    View Post
  • Dermatology / October 10, 2020

    Eosinophilic folliculitis due to wearing protective gear in citizens volunteering for sanitation services during the COVID-19 pandemic – an original epidemiological, clinical, dermoscopic, and laboratory-based study.

    View Post
  • Dermatology / April 12, 2021

    Stevens-Johnson syndrome and toxic epidermal necrolysis in a referral center in Taiwan.

    View Post

Dermatologic Infections in Cancer Patients Treated with Checkpoint Inhibitors.

In Dermatology
by ClinOwl
March 21, 2021

The incidence of dermatologic infections in patients receiving checkpoint inhibitors (CPIs) has not been systematically described.Identify the incidence of dermatologic infections in patients who received CPIs and were evaluated by …

The risk of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid and pemphigus: A population-based cohort study.

In Dermatology
by ClinOwl
March 21, 2021

The burden of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid (BP) and pemphigus is yet to be evaluated.To assess the risk of COVID-19, and COVID-19-associated hospitalization and mortality …

Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults With Moderate-to-severe Atopic Dermatitis.

In Dermatology
by ClinOwl
March 21, 2021

Atopic dermatitis (AD) is a chronic inflammatory skin disease. Interleukin (IL)-13, a type 2 cytokine, is key in AD inflammation. Tralokinumab is a first-in-class, fully human, monoclonal antibody that specifically …

Skin cancer in non-white liver transplant recipients: Mayo Clinic experience.

In Dermatology
by ClinOwl
March 20, 2021

Limited data are available on the development of skin cancer and the associated risk factors for non-White liver transplant (LT) recipients. The aim of this study is to determine the …

Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis.

In Dermatology
by ClinOwl
March 20, 2021

Skin aging has become a recurring concern even for younger people, mainly owing to increased life expectancy. In this context, the use of nutricosmetics as supplements has increased in recent …

Journal attitudes and outcomes of preprints in dermatology.

In Dermatology
by ClinOwl
March 19, 2021

The use of preprints, manuscripts that can be uploaded to a public server and made almost immediately available for public dissemination without peer review, is becoming increasingly common.1 Preprint servers …

Management of skin thinning and aging: review of therapies for neocollagenesis; hormones and energy devices.

In Dermatology
by ClinOwl
March 19, 2021

Hormone replacement therapy and various devices exist to treat signs of aging, such as skin thinning, yet there are no reviews summarizing or evaluating their role in neocollagenesis and the …

Managing pain associated with dermatologic procedures.

In Dermatology
by ClinOwl
March 19, 2021

Dermatologists are faced with an aging population, accompanied by an increase in the incidence of skin cancer, especially nonmelanoma skin cancer. With this increase in cutaneous malignancy comes an increase …

Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.

In Dermatology
by ClinOwl
March 19, 2021

Pyoderma gangrenosum is a rare neutrophilic dermatosis that is commonly treated with systemic corticosteroids; however, their potent side effects may warrant tapering, and non-steroidal systemic immunosuppressants may help maintain or …

Oral corticosteroid bursts and severe adverse events: a critical appraisal.

In Dermatology
by ClinOwl
March 19, 2021

Short-term corticosteroids are commonly used to treat various dermatoses. Previous study has indicated oral corticosteroids < 30 days duration increased the risk of gastrointestinal (GI) bleedings, fractures, venous thromboembolism and sepsis.1 …

  • Page 21 of 57
  • ←
  • 1
  • ...
  • 20
  • 21
  • 22
  • ...
  • 57
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer